/ /

  • linkedin
  • Increase Font
  • Sharebar

    Home monitoring for AMD may have substantial impact on U.S. public health

    Use may result in hundreds of thousands of patients optimizing vision over time

     

    “Comparing such estimates from the community, home device monitoring may result in another approximately 200,000 people retaining good functional vision,” Dr. Regillo said.

    Glaucoma more common in people with lower income

    When an estimation of those who are at high risk for developing CNV and can use the device, between 100,000 to 300,000 additional patients in the United States would be detected at 20/40 or better over the next 5 years. The potential impact on public health in the United States may be considerable with more than 60% of patients likely to maintain 20/40 or better for at least 2 years on anti-vascular endothelial growth factor therapy, Dr. Regillo noted.

    The usability of the device by older patients is a consideration. A recent study from the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, supported use of the device in this study population and showed that usability was high, i.e., more than 80% and not associated with age (Chaikitmongkol V et al. Retin Cases Brief Rep. 2015;9:33-37).

     

    Carl Regillo, MD

    E: [email protected]

    This article was adapted from Dr. Regillo’s presentation at the 2015 meeting of the American Society of Retina Specialists. Dr. Regillo received research grant support from Notal Vision. The study was performed by the AREDS2 investigators and sponsored by Notal Vision, in collaboration with the National Eye Institute.

     

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results